Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Watson

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical and Translational Gastroenterology|October 31, 2019
Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and CancerWen-Sy Tsai, Jeng-Fu You, Hsin-Yuan Hung, et al.
European Urology Oncology|April 26, 2025
Presence of an Artificial Intelligence-powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non-muscle-invasive Bladder CancerVignesh T Packiam, Ian M McElree, Saum Ghodoussipour, et al.
Clinical Lung Cancer|April 16, 2026
Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint InhibitorsMark Klein, Drew Watson, Michael Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2011
Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancerChungyeul Kim, Gong Tang, Katherine L Pogue-Geile, et al.
BMC Cancer|July 2, 2020
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myelomaTravers Ching, Megan E Duncan, Tera Newman-Eerkes, et al.
European Urology|June 13, 2025
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification SchemesSam S Chang, Bryn Launer, Vikram Narayan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic CancerAndrew E Hendifar, Viswesh Krishna, Vrishab Krishna, et al.
The Journal of Urology|October 9, 2024
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center CohortYair Lotan, Viswesh Krishna, Waleed M Abuzeid, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical and Translational Gastroenterology|October 31, 2019
Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and CancerWen-Sy Tsai, Jeng-Fu You, Hsin-Yuan Hung, et al.
European Urology Oncology|April 26, 2025
Presence of an Artificial Intelligence-powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non-muscle-invasive Bladder CancerVignesh T Packiam, Ian M McElree, Saum Ghodoussipour, et al.
Clinical Lung Cancer|April 16, 2026
Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint InhibitorsMark Klein, Drew Watson, Michael Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2011
Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancerChungyeul Kim, Gong Tang, Katherine L Pogue-Geile, et al.
BMC Cancer|July 2, 2020
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myelomaTravers Ching, Megan E Duncan, Tera Newman-Eerkes, et al.
European Urology|June 13, 2025
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non-muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification SchemesSam S Chang, Bryn Launer, Vikram Narayan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic CancerAndrew E Hendifar, Viswesh Krishna, Vrishab Krishna, et al.
The Journal of Urology|October 9, 2024
Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center CohortYair Lotan, Viswesh Krishna, Waleed M Abuzeid, et al.
Pageof 3